Arax Advisory Partners Reduces Position in RTX Corporation $RTX
Arax Advisory Partners significantly decreased its stake in RTX Corporation by 49.7% in the fourth quarter, selling 37,294 shares and ending with holdings worth $6.918 million. Despite this reduction from one firm, other institutional investors have recently acquired new stakes or increased their positions in RTX. The article also provides details on RTX's financial performance, recent dividend increase, and mentions several positive analyst upgrades and news, such as an expansion of its Collins Aerospace unit.
11,829 Shares in Texas Instruments Incorporated $TXN Purchased by Atlas Capital Advisors Inc.
Atlas Capital Advisors Inc. recently purchased 11,829 shares of Texas Instruments (NASDAQ:TXN) stock, valued at approximately $2.05 million, according to its latest 13F filing. Other institutional investors also acquired new stakes in the semiconductor company. The article also details recent analyst ratings, notable insider selling by Texas Instruments executives, and the company's financial performance, including its dividend announcement and recent earnings report.
Adams Natural Resources Fund Inc. Sells 59,800 Shares of Occidental Petroleum Corporation $OXY
Adams Natural Resources Fund Inc. reduced its stake in Occidental Petroleum Corporation by 23.9% in the fourth quarter, selling 59,800 shares. Despite the sell-off, Occidental Petroleum remains a significant part of the fund's portfolio. Other institutional investors have made various adjustments to their holdings in OXY, which has a current consensus rating of "Hold" among analysts.
8 Knots Management LLC Sells 659,963 Shares of CVS Health Corporation $CVS
8 Knots Management LLC significantly reduced its stake in CVS Health Corporation (NYSE:CVS) during the fourth quarter, selling 659,963 shares and decreasing its holdings by 56.2%. Despite this, CVS Health remains 8 Knots Management LLC's sixth-largest holding. The article also details other institutional investor activity, CVS Health's financial performance, recent dividend announcements, insider trades, and current analyst ratings, with the company showing strong revenue and EPS growth and a "Moderate Buy" consensus rating from analysts.
Atlas Capital Advisors Inc. Invests $2.96 Million in CVS Health Corporation $CVS
Atlas Capital Advisors Inc. has invested approximately $2.96 million in CVS Health Corporation by purchasing 37,231 shares during the fourth quarter. This move comes as other institutional investors have also adjusted their positions in CVS. The article highlights recent analyst ratings, significant insider selling, and positive news regarding CVS Health's strategic initiatives in GLP-1 access, AI integration, and mental health services.
CVS Health Corporation $CVS Shares Bought by Adams Diversified Equity Fund Inc.
Adams Diversified Equity Fund Inc. significantly increased its stake in CVS Health Corporation by 175.5% in the fourth quarter, owning 351,300 shares worth $27.88 million. Other institutional investors also adjusted their holdings, while CVS insiders recently sold a substantial number of shares. The article also highlights recent positive news for CVS, including its expansion of GLP-1 weight-loss drug access, AI integration, and new mental health services, alongside analyst ratings and financial performance data.
Adams Diversified Equity Fund Inc. Takes $18.38 Million Position in Dollar General Corporation $DG
Adams Diversified Equity Fund Inc. recently acquired a new stake of $18.38 million in Dollar General Corporation (NYSE:DG) during the fourth quarter, purchasing 138,400 shares. This highlights continued institutional interest in Dollar General, with other hedge funds also adjusting their positions in the company. The article also provides a financial overview of Dollar General, including its stock performance, recent earnings, dividend announcement, and current analyst ratings.
Adams Natural Resources Fund Inc. Reduces Position in Corteva, Inc. $CTVA
Adams Natural Resources Fund Inc. decreased its holdings in Corteva, Inc. by 37.0% in the fourth quarter, selling 34,000 shares and now owning 57,945 shares valued at $3.88 million. Despite this reduction, many other institutional investors increased their stakes in Corteva. The stock holds a "Moderate Buy" consensus rating with an average price target of $88.81 among analysts, and the company recently declared a quarterly dividend of $0.18 per share.
Adams Diversified Equity Fund Inc. Invests $19.03 Million in Rockwell Automation, Inc. $ROK
Adams Diversified Equity Fund Inc. recently acquired a new position in Rockwell Automation, Inc. (NYSE:ROK) valued at approximately $19.03 million during the fourth quarter. Other institutional investors have also adjusted their holdings, with Nordea Investment Management AB significantly boosting its stake. The article also provides an overview of recent analyst ratings, insider trading activities, and Rockwell Automation's financial performance, including its latest earnings beat, dividend announcement, and a $1 billion share buyback plan.
Adams Diversified Equity Fund Inc. Sells 9,224 Shares of PepsiCo, Inc. $PEP
Adams Diversified Equity Fund Inc. has reduced its stake in PepsiCo, Inc. by 19.3% in the fourth quarter, selling 9,224 shares and now owning 38,576 shares worth $5.54 million. Despite this, other major institutional investors like Vanguard Group, State Street Corp, and Geode Capital Management LLC increased their holdings in PepsiCo, with institutional ownership standing at 73.07%. Recent analyst reports show mixed sentiment, with some price target cuts but an overall "Hold" rating for the stock, while PepsiCo also announced an increased quarterly dividend.




